Progyny projects revenue growth for Q2 2026 while expanding its client base by over 1 million new lives.
Progyny announced a revenue forecast of $1.36 billion to $1.385 billion for Q2 2026, reflecting solid year-over-year growth. The company also aims to add more than 1 million new lives to its client base during the period.
The guidance follows a record quarterly performance, with increases in revenue, gross profit, and adjusted EBITDA, alongside gross margin expansion. Prior-year comparisons highlight consistent growth trends.
No immediate market reaction was disclosed in the earnings call insights.